March 16 (Reuters) - Arch Biopartners Inc ARCH.V :
* ARCH BIOPARTNERS RECEIVES HEALTH CANADA AUTHORIZATION TO AMEND PHASE II TRIAL PROTOCOL FOR LSALT PEPTIDE
March 16 (Reuters) - Arch Biopartners Inc ARCH.V :
* ARCH BIOPARTNERS RECEIVES HEALTH CANADA AUTHORIZATION TO AMEND PHASE II TRIAL PROTOCOL FOR LSALT PEPTIDE